Drawing for PEMFINDER

USPTO serial 79015568

PEMFINDER

Reviewed by CopyMark Law Group

Reg. 3218185Status 404
Filing date
Status date
Registration date
Mar 13, 2007
Examiner
PERRY, KIMBERLY B
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PEMFINDER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson St. NW, Suite 400Washington, DC 20007UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science [ chemical preparations for use in agriculture, namely, chemical preparations for the treatment of seeds; and chemical preparations for use in photography, namely, chemical developers, unprocessed artificial resins as raw materials in the form of powders, liquids or pastes, unprocessed plastics for industrial use, unprocessed plastics in all forms; manures; fire extinguishing compositions; tempering chemicals for use in metalworking or soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather, adhesives for general industrial use ]SECTION 70 - CANCELLED
003[ Bleaching preparations for household use, general purpose cleaning, polishing, scouring and abrasive liquids and powders soaps; soaps; perfumery, essential oils for personal use and for use as ingredients in the manufacture of cosmetic preparations, cosmetics, hair lotions; dentifrices ]SECTION 71 - CANCELLED
005[ Pharmaceutical anti-allergic preparations and substances, ] Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations namely, anticoagulants, Pharmaceutical preparations namely, antidepressants, Pharmaceutical preparations namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals for the treatment of erectile dysfunction, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; and Veterinary preparations, namely, pain relief medication, veterinary preparations for the treatment of intestinal bacteria, [ Veterinary vaccine for horses, Veterinary vaccines; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, dressings for wounds, burns, surgery; dental impression materials; disinfectants for hygienic purposes; preparations for destroying vermin; fungicides, herbicides ]SECTION 70 - CANCELLED
042Scientific and technological services in the nature of research in the field of agrochemicals, pharmaceuticals and bio-chemistry and design services relating thereto; [ industrial analysis and research services; design and development of computer hardware and software; legal services ]SECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 2, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 2, 2026DETHDEATH OF INTERNATIONAL REGISTRATION
Mar 13, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Oct 29, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
May 7, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Jul 19, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED
Mar 23, 2018INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Feb 12, 2018INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 12, 2018INPCINVALIDATION PROCESSED
Feb 7, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 7, 2017NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 7, 201771AGREGISTERED-SEC.71 ACCEPTED
Jun 7, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 13, 2017ES71TEAS SECTION 71 RECEIVED
Mar 13, 2016REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 24, 2015RNWLINTERNATIONAL REGISTRATION RENEWED
Apr 24, 2015XXSSGENERIC MADRID TRANSACTION SENT TO IB
Apr 24, 2015XXCRGENERIC MADRID TRANSACTION CREATED
Apr 10, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Nov 17, 2014INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 11, 2014INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 17, 2014NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 17, 201471.PREGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 24, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2014EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 21, 2013INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 13, 2013PR71POST REGISTRATION ACTION MAILED - SEC.71
Sep 13, 2013PR71POST REGISTRATION ACTION MAILED - SEC.71
Aug 27, 201371AFREGISTERED-SEC.71 FILED
Aug 27, 2013ES71TEAS SECTION 71 RECEIVED
Aug 27, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2013PR71POST REGISTRATION ACTION MAILED - SEC.71
Mar 21, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 25, 2013ES71TEAS SECTION 71 RECEIVED
Oct 9, 2009TMBNTTAB RELEASE CASE TO TRADEMARKS
Oct 9, 2009CANTCANCELLATION TERMINATED NO. 999999
Oct 9, 2009CANDCANCELLATION DENIED NO. 999999
May 4, 2009PETCCANCELLATION INSTITUTED NO. 999999
Jun 27, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 22, 2008ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 18, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 18, 2007FIMPFINAL DISPOSITION PROCESSED
Sep 10, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 13, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 26, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 6, 2006NPUBNOTICE OF PUBLICATION
Oct 31, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 13, 2006ALIEASSIGNED TO LIE
Oct 6, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2006CNEAEXAMINERS AMENDMENT MAILED
Oct 5, 2006XAECEXAMINER'S AMENDMENT ENTERED
Oct 5, 2006CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 19, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 19, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2006RFNTREFUSAL PROCESSED BY IB
Mar 23, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 22, 2006RFRRREFUSAL PROCESSED BY MPU
Mar 21, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2006DOCKASSIGNED TO EXAMINER
Oct 24, 2005NWAPNEW APPLICATION ENTERED
Oct 20, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance